Territory Manager
Mineralys Therapeutics
Territory Manager
Mineralys Therapeutics
Clinical-stage biopharma targeting aldosterone synthesis
“Mineralys Therapeutics is a clinical-stage biopharmaceutical company focused on developing medicines to target hypertension and related comorbidities such as chronic kidney disease (CKD), obstructive sleep apnea (OSA) and other diseases driven by dysregulated aldosterone. Its initial product candidate, lorundrostat, is a proprietary, orally administered, highly selective aldosterone synthase inhibitor. Mineralys is headquartered in Radnor, Pennsylvania. For more information, please visit https://mineralystx.com. Follow Mineralys on LinkedIn, Twitter and Bluesky”
Mineralys is a fully remote company.
Territory Manager
Position Summary
The Territory Manager will play a critical role in the successful launch and growth of Mineralys’ first commercial product within an assigned territory. This individual will be responsible for educating healthcare providers (HCPs) on Mineralys’ product, building trusted customer relationships, driving product adoption, and achieving territory sales performance goals.
This is a highly visible role requiring strong selling skills, customer engagement capabilities, and a passion for improving outcomes for patients with uncontrolled hypertension. The ideal candidate thrives in a fast-paced, entrepreneurial biotech environment and is energized by the opportunity to launch a breakthrough new class of medicine.
Key Responsibilities
Territory Management / Business Execution
Customer Engagement / Selling Excellence
Cross-Functional Collaboration
Compliance / Culture
Qualifications
Success Profile
Travel
These positions are eligible for standard Company benefits including medical, dental, vision, time off and 401K, as well as participating in Mineralys incentive plans are contingent on achievement of personal and company performance. Actual compensation may vary from posted hiring range based on geographic location, work experience, education, and/or skill level.
US Salary Range: $130,000 - $165,000
#LI-REMOTE
Clinical-stage biopharma targeting aldosterone synthesis
Mineralys Therapeutics develops targeted treatments for diseases driven by dysregulated aldosterone, aiming to control blood pressure and prevent organ damage, led by lorundrostat. Lorundrostat is an oral aldosterone synthase inhibitor that blocks the CYP11B2 enzyme to lower aldosterone production, designed to reduce blood pressure with minimal cortisol disruption due to high selectivity. Compared with older non-selective MRAs, it lowers side effects by focusing on aldosterone synthesis rather than receptor blockade. The company's goal is to advance lorundrostat through late-stage trials toward regulatory approval and commercialization, while exploring expanded uses in CKD and OSA for a potential multi-hundred-billion market.
Explore more opportunities at Mineralys Therapeutics